August 23, 2026 a 09:31 am
Healthcare Stocks - Performance Analysis 📊
The healthcare sector has demonstrated both volatility and growth, with varied performances across significant players. The one-week data reveals rapid shifts, while the monthly trend highlights sustained movements. As we delve into the quarterly perspective, some consistent performers and innovations emerge, offering key insights into future market movements.
Healthcare Stocks Performance One Week 📉
| Stock | Performance (%) | Performance |
|---|---|---|
| MRK | 12.39% | |
| TMO | 6.84% | |
| LLY | 6.38% | |
| ABBV | 6.14% | |
| AMGN | 5.77% | |
| ABT | 4.79% | |
| JNJ | 3.82% | |
| UNH | -2.90% | |
| ISRG | -3.85% |
Healthcare Stocks Performance One Month 📈
| Stock | Performance (%) | Performance |
|---|---|---|
| MRK | 16.04% | |
| AMGN | 15.98% | |
| ABT | 12.56% | |
| ISRG | 12.30% | |
| TMO | 10.45% | |
| LLY | 5.47% | |
| JNJ | 2.74% | |
| ABBV | 2.39% | |
| UNH | -7.37% |
Healthcare Stocks Performance Three Months 📊
| Stock | Performance (%) | Performance |
|---|---|---|
| TMO | 35.40% | |
| ABT | 30.16% | |
| AMGN | 26.79% | |
| MRK | 23.68% | |
| ABBV | 21.66% | |
| LLY | 17.96% | |
| JNJ | 15.04% | |
| UNH | 1.19% | |
| ISRG | -11.62% |
Summary ✅
Across these three temporal frameworks, Thermo Fisher Scientific (TMO) has shown exemplary performance, especially over the quarter. Abbott Laboratories (ABT) also stands out with robust returns. Conversely, UnitedHealth Group (UNH) and Intuitive Surgical (ISRG) face challenges, impacting their recent stock movements negatively. Investors may consider exploring these outperformers while cautiously monitoring underperformers. The dynamic nature of the healthcare sector suggests that innovation and strategic growth decisions are crucial for sustained success.
Smart Data Insight
Master the Perfect Entry & Exit for this Stock
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.
- ✅ Identify the "Golden Buying Window"
- ✅ Avoid high-risk correction cycles
- ✅ Backtested data from the last 20+ years